M. Szkultecka-Debek: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

PCN4 BUDGET IMPACT ANALYSIS OF ADJUVANT THERAPY WITH TRASTUZUMAB FOR HER2-POSITIVE EARLY BREAST CANCER IN POLISH SETTING

E Orlewska, R Aultman, M Krzakowski, T Pienkowski, K Drosik, M Szkultecka-Debek

Journal:

Value in Health

Year:

2007

Language:

english

File:

PDF, 70 KB

english, 2007

2

PCN7 COST-EFFECTIVENESS ANALYSIS OF ADJUVANT THERAPY WITH TRASTUZUMAB FOR HER2-POSITIVE EARLY BREAST CANCER IN POLISH SETTING

E Orlewska, T Pienkowski, K Drosik, M Gyldmark, R Aultman, M Szkultecka-Debek

Journal:

Value in Health

Year:

2007

Language:

english

File:

PDF, 68 KB

english, 2007

3

PCN77 COST-EFFECTIVENESS ANALYSIS OF ERLOTINIB IN THE TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) IN ROMANIA

TE Ciuleanu, M Dediu, LN Minea, S Baculea, M Szkultecka-Debek

Journal:

Value in Health

Year:

2010

Language:

english

File:

PDF, 77 KB

english, 2010

4

PCN98 COST-EFFECTIVENESS OF ADJUVANT THERAPY WITH TRASTUZUMAB IN THE TREATMENT OF EARLY BREAST CANCER (EBC) IN ROMANIA

D Grecea, S Baculea, PC Radu, B Pana, M Szkultecka-Debek

Journal:

Value in Health

Year:

2010

Language:

english

File:

PDF, 78 KB

english, 2010

5

PCN21 BUDGET IMPACT ANALYSIS OF NON – SMALL CELL LUNG CARCINOMA (NSCLC) TREATMENT WITH ERLOTINIB IN POLISH SETTING

E Orlewska, A Szczesna, M Szkultecka-Debek

Journal:

Value in Health

Year:

2009

Language:

english

File:

PDF, 127 KB

english, 2009

6

PCN88 AN ECONOMIC EVALUATION OF RITUXIMAB VERSUS OTHER FIRST-LINE TREATMENTS FOR PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA IN POLAND

P Kawalec, E Stawowczyk, M Russel-Szymczyk, M Szkultecka-Debek, R Aultman, E Carr, E Lech-Maranda, A Krawcewicz, M Wach, G Mazur

Journal:

Value in Health

Year:

2009

Language:

english

File:

PDF, 72 KB

english, 2009

7

PUK11 COST-MINIMIZATION ANALYSIS: MIRCERA (METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA) VS. ARANESP (DARBEPOETIN ALFA) IN PATIENTS WITH CHRONIC KIDNEY DISEASE (CKD) WHO ARE NOT RECEIVING HAEMODIALYSIS, IN POLISH SETTING

P Kawalec, J Kuzma, M Szkultecka-Debek, M Russel-Szymczyk, A Slizien-Debska, J Malyszko, M Durlik

Journal:

Value in Health

Year:

2009

Language:

english

File:

PDF, 81 KB

english, 2009

8

PCN34 BUDGET IMPACT ANALYSIS OF CAPECITABINE IN ADJUVANT TREATMENT OF PATIENTS WITH RESECTED DUKES' C COLON CANCER (CC) FROM POLISH PUBLIC PAYER'S AND PATIENT'S PERSPECTIVES

R Oleszko, P Kawalec, A Drobniak, R Stec, J Streb, M Russel-Szymczyk, M Szkultecka-Debek

Journal:

Value in Health

Year:

2010

Language:

english

File:

PDF, 70 KB

english, 2010

9

PCN91 BEVACIZUMAB + PACLITAXEL + CARBOPLATIN (BEV + PAC + CAR) VS. PEMETREXED + CISPLATIN (PEM + CIS) IN ADENOCARCINOMA NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC): A COST-EFFECTIVENESS ANALYSIS FROM A POLISH PUBLIC PAYER'S PERSPECTIVE

P Kawalec, P Badurak, T Denisso, D Jastrzebski, M Marek, A Pluzanski, A Szczesna, M Szkultecka-Debek, M Russel-Szymczyk

Journal:

Value in Health

Year:

2010

Language:

english

File:

PDF, 77 KB

english, 2010

10

PIN55 Cost-Effectiveness Analysis of Peginterferon Alfa-2A (40KD) in HBEAG-Positive Chronic Hepatitis B in Poland

M. Jakubczyk, J. Pawęska, M. Niewada, H. Berak, M. Szkultecka-Dębek, M. Russel-Szymczyk

Journal:

Value in Health

Year:

2011

Language:

english

File:

PDF, 62 KB

english, 2011

11

PIN67 Cost-Effectiveness Analysis of Peginterferon Alfa-2A (40KD) in HBEAG-Negative Chronic Hepatitis B in Poland

M. Jakubczyk, J. Pawèska, M. Niewada, H. Berak, M. Szkultecka-dèbek, M. Russel-szymczyk

Journal:

Value in Health

Year:

2011

Language:

english

File:

PDF, 62 KB

english, 2011

12

PIN53 Cost-Effectiveness Analysis of Pegylated Interferon Alpha-2A Versus Pegylated Interferon Alpha-2B in the Treatment of Chronic Hepatitis C Patients in Poland

T. Macioch, J. Paweska, M. Niewada, H. Berak, M. Szkultecka-Debek, M. Russel-Szymczyk

Journal:

Value in Health

Year:

2011

Language:

english

File:

PDF, 74 KB

english, 2011

13

PCN12 COST EFFECTIVENESS OF ERLOTINIB IN THE TREATMENT OF ADVANCED NON SMALL CELL LUNG CANCER (NSCLC) IN POLAND

E Orlewska, A Szczesna, M Gyldmark, M Szkultecka-Debek

Journal:

Value in Health

Year:

2006

Language:

english

File:

PDF, 66 KB

english, 2006

14

PIN5 THE COST EFFECTIVENESS ANALYSIS OF TREATMENT WITH PEGINTERFERON ALFA-2A (40KD) IN PATIENTS WITH HBEAG-NEGATIVE CHRONIC HEPATITIS B

E Kowalik, M Niewada, M Jakubczyk, A Horban, H Berak, M Szkultecka-Debek

Journal:

Value in Health

Year:

2006

Language:

english

File:

PDF, 72 KB

english, 2006

15

PUK5 COSTS AND COST-EFFECTIVENESS OF EPOETIN IN PATIENTS WITH CHRONIC RENAL INSUFFICIENCY DURING THE PREDIALYSIS PERIOD IN POLAND

M Niewada, E Kowalik, M Jakubczyk, B Rutkowski, M Szkultecka-Debek

Journal:

Value in Health

Year:

2006

Language:

english

File:

PDF, 88 KB

english, 2006

16

PUK8 CMA OF MYCOPHENOLAN MOFETIL (MMF; CELLCEPT) OR TACROLIMUS (TAC; PROGRAF) IN KIDNEYTRANSPLANT IMMUNOSUPPRESSIVE THERAPY SCHEMES FROM PUBLIC PAYER'S PERSPECTIVE IN POLAND

P Kawalec, M Szkultecka-Debek, M Russel

Journal:

Value in Health

Year:

2007

Language:

english

File:

PDF, 71 KB

english, 2007

17

PCN44 COST MINIMIZATION ANALYSIS OF ADVANCED GASTRIC CANCERTREATMENT WITH CAPECITABINE/CISPLATIN (XP) VS. 5-FU/CISPLATIN (FP) REGIMENS IN POLISH SETTING

P Kawalec, A Szawlowski, I Federowicz, M Szkultecka-Debek, M Russel-Szymczyk

Journal:

Value in Health

Year:

2008

Language:

english

File:

PDF, 71 KB

english, 2008

18

PMS35 RHEUMATOID ARTHRITIS COST STUDY RESULTS IN POLAND

J Lacki, P Rys, R Plisko, K Szamotulska, M Szkultecka-Debek, M Russel-Szymczyk

Journal:

Value in Health

Year:

2008

Language:

english

File:

PDF, 73 KB

english, 2008

19

PMS25 COST-EFFECTIVENESS OF RITUXIMAB (MABTHERA) COMPARED WITH TNF INHIBITORS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS (RA) IN POLAND

R Plisko, J Krzystek, P Rys, M Russel-Szymczyk, M Szkultecka-Debek, K Szamotulska

Journal:

Value in Health

Year:

2008

Language:

english

File:

PDF, 74 KB

english, 2008

20

Schizophrenia and Negative Symptoms – Burden of the Disease in Seven Central and Eastern European (CEE) Countries: THE Results of the Literature Review

Walczak, J., Augustyńska, J., Miernik, K., Stelmachowski, J., Pieniazek, I., Obrzut, G., Pogroszewska, A., Szkultecka-Debek, M., Paulic, G., Maric, D., Sinisa, A., Pecenak, J., Tavcar, R., Indrikson,

Journal:

Value in Health

Year:

2013

Language:

english

File:

PDF, 78 KB

english, 2013

21

Methodology and Development of ‘Polish Dictionary of Quality of Life Terms’

Golicki, D., Farkowski, M.M., Grabowska-Krawiec, P., Szkultecka-Debek, M., Zawodnik, S., Baran, J., Borowiec, L., Czech, M.

Journal:

Value in Health

Year:

2013

Language:

english

File:

PDF, 57 KB

english, 2013

22

The Direct Costs of Drug-Induced Skin Reactions in Poland

Wisniewska, N., Szkultecka-Debek, M., Owczarek, W., Paluchowska, B., Jahnz-Rozyk, K.

Journal:

Value in Health

Year:

2013

Language:

english

File:

PDF, 62 KB

english, 2013

23

Costs Comparison of Cutaneous Drug Reactions Treatment Divided by Diagnosis Groups

Wisniewska, N., Szkultecka-Debek, M., Owczarek, W., Paluchowska, E.B., Jahnz-Rozyk, K.M.

Journal:

Value in Health

Year:

2013

Language:

english

File:

PDF, 58 KB

english, 2013

24

PCN86 Cost-Effectiveness of Rituximab in Follicular Lymphoma First Line Maintenance Treatment from Public Payer Perspective in Poland

Gadaj, A., Kalinowska, A., Hawrylecka, D., Holojda, J., Krawcewicz, A., Spychalowicz, W., Russel-Szymczyk, M., Szkultecka-debek, M.

Journal:

Value in Health

Year:

2011

Language:

english

File:

PDF, 70 KB

english, 2011

25

PRS5 Analysis Of Efficacy and Safety of Dornase Alfa in The Treatment of Cystic Fibrosis

Kaczor, M., Wojcik, R., Rolka, M., Banas, P., Niewiara, L., Kaczynski, L., Russel-Szymczyk, M., Szkultecka-Debek, M.

Journal:

Value in Health

Year:

2011

Language:

english

File:

PDF, 59 KB

english, 2011

26

Direct Costs of Treatment of Skin Drug Reactions Induced by Antibiotics in Perspective of Public Payer and Service Provider

Wisniewska, N., Jahnz-Rozyk, K.M., Paluchowska, E.B., Owczarek, W., Szkultecka-Debek, M.

Journal:

Value in Health

Year:

2014

Language:

english

File:

PDF, 62 KB

english, 2014

27

Treatment Rates in Patients with HER2+ Metastatic Breast Cancer and the Factors Influencing Treatment Decision

Colomer, R, Hall, P, szkultecka-Debek, M, Bondi, R, Flinois, A, Auziere, S, Le Cleach, J

Journal:

Value in Health

Year:

2016

Language:

english

File:

PDF, 99 KB

english, 2016

28

Response to Targeted Therapy and Healthcare Resource Utilization (HRU): A European Retrospective Chart Review Study in Patients With HER2+ Metastatic Breast Cancer

Colomer, R, Hall, P, szkultecka-Debek, M, Bondi, R, Flinois, A, Le Cleach, J

Journal:

Value in Health

Year:

2016

Language:

english

File:

PDF, 73 KB

english, 2016

29

Drug Policy in Latvia

Silins, Janis, Szkultecka-Dębek, Monika

Journal:

Value in Health Regional Issues

Year:

2017

Language:

english

File:

PDF, 375 KB

english, 2017

30

Drug Policies in Central and Eastern European Countries

Janhz-Różyk, Karina, Kawalec, Paweł, Szkultecka-Debek, Monika

Journal:

Value in Health Regional Issues

Year:

2017

Language:

english

File:

PDF, 299 KB

english, 2017

31

Drug Policy in Croatia

Culig, Josip, Antolic, Sinisa, Szkultecka-Dębek, Monika

Journal:

Value in Health Regional Issues

Year:

2017

Language:

english

File:

PDF, 701 KB

english, 2017

32

Real-world treatment in patients with HER2+ metastatic breast cancer

Colomer, R., Hall, P., Szkultecka-Debek, M., Bondi, R. C., Flinois, A., Auziere, S., Le Cléac’h, J. Y.

Journal:

Breast Cancer Research and Treatment

Year:

2018

Language:

english

File:

PDF, 693 KB

english, 2018

33

Drug Policy in Estonia

Mägi, Kadri, Lepaste, Marika, Szkultecka-Dębek, Monika

Journal:

Value in Health Regional Issues

Year:

2018

Language:

english

File:

PDF, 670 KB

english, 2018

34

What does the Cantril Ladder measure in adolescence?

Mazur, Joanna, Szkultecka-Dębek, Monika, Dzielska, Anna, Drozd, Mariola, Małkowska-Szkutnik, Agnieszka

Journal:

Archives of Medical Science

Year:

2018

Language:

english

File:

PDF, 84 KB

english, 2018

35

P3-147: Budget impact analysis of erlotinib in the treatment of advanced non–small–cell lung cancer (NSCLC) in Poland

Orlewska, Ewa, Szczêsna, Aleksandra, Szkultecka-Dêbek, Monika

Journal:

Journal of Thoracic Oncology

Year:

2007

Language:

english

File:

PDF, 164 KB

english, 2007